Electric field therapy plus immunotherapy tested for tough lung cancers
Disease control
Terminated
This study tested a wearable device that sends low-intensity electric fields to tumors, combined with the immunotherapy drug pembrolizumab, in people with advanced non-small cell lung cancer that had already been treated with chemotherapy and immunotherapy. The goal was to see if…
Phase: PHASE2 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated Jun 17, 2026 07:30 UTC